Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients.
作者信息
Ergenc Ilkay, Gozaydinoglu Busra, Keklikkiran Caglayan, Yilmaz Yusuf
机构信息
Department of Gastroenterology, Marmara University School of Medicine, Istanbul, Turkiye.
Institute of Gastroenterology, Marmara University, Istanbul, Turkiye.
出版信息
Hepatol Forum. 2024 Jul 2;5(3):165-166. doi: 10.14744/hf.2024.2024.0007. eCollection 2024.
Abstract
摘要
相似文献
1
Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients.线粒体M2抗体偶然阳性患者的最佳检测策略
Hepatol Forum. 2024 Jul 2;5(3):165-166. doi: 10.14744/hf.2024.2024.0007. eCollection 2024.
2
Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients.线粒体M2抗体偶然阳性患者的最佳检测策略
Hepatol Forum. 2024 Jan 16;5(1):49. doi: 10.14744/hf.2023.2023.0043. eCollection 2024.
3
The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients.偶然抗线粒体M2抗体阳性患者发生原发性胆汁性胆管炎的风险。
Hepatol Forum. 2023 May 18;4(2):69-73. doi: 10.14744/hf.2023.2023.0016. eCollection 2023 Mar.
4
Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited.原发性胆汁性肝硬化中的线粒体抗原/抗体系统：再探讨
Liver. 1995 Dec;15(6):281-92. doi: 10.1111/j.1600-0676.1995.tb00687.x.
5
6
Anti-mitochondrial M2 antibody-positive autoimmune hepatitis.抗线粒体M2抗体阳性自身免疫性肝炎
Exp Ther Med. 2015 Oct;10(4):1419-1422. doi: 10.3892/etm.2015.2694. Epub 2015 Aug 20.
7
Clinical features of anti-mitochondrial M2 antibody-positive myositis: case series of 17 patients.抗线粒体 M2 抗体阳性肌炎的临床特征：17 例患者的病例系列。
J Neurol Sci. 2022 Nov 15;442:120391. doi: 10.1016/j.jns.2022.120391. Epub 2022 Aug 28.
8
[Establishment of the optimal conditions for detecting anti-M2 by western blotting in primary biliary cirrhosis].[原发性胆汁性肝硬化中通过蛋白质印迹法检测抗M2的最佳条件的建立]
Rinsho Byori. 1997 Nov;45(11):1072-8.
9
Dilated cardiomyopathy with anti-mitochondrial M2 antibody: A case series.伴有抗线粒体M2抗体的扩张型心肌病：病例系列
J Cardiol Cases. 2023 Mar 7;28(1):11-15. doi: 10.1016/j.jccase.2023.02.021. eCollection 2023 Jul.
10
Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.使用“MESACUP - 2检测线粒体M2”试剂盒对新开发的酶联免疫吸附测定法在原发性胆汁性肝硬化诊断中的评估。
Clin Biochem. 2003 May;36(3):203-10. doi: 10.1016/s0009-9120(02)00439-3.
本文引用的文献
1
Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients.线粒体M2抗体偶然阳性患者的最佳检测策略
Hepatol Forum. 2024 Jan 16;5(1):49. doi: 10.14744/hf.2023.2023.0043. eCollection 2024.
2
The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients.偶然抗线粒体M2抗体阳性患者发生原发性胆汁性胆管炎的风险。
Hepatol Forum. 2023 May 18;4(2):69-73. doi: 10.14744/hf.2023.2023.0016. eCollection 2023 Mar.
3
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases.原发性胆汁性胆管炎：美国肝病研究协会2018年实践指南
Hepatology. 2019 Jan;69(1):394-419. doi: 10.1002/hep.30145. Epub 2018 Nov 6.
4
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.EASL 临床实践指南：原发性胆汁性胆管炎患者的诊断和管理。
J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Epub 2017 Apr 18.
Zotero 插件